EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access

Development of 18 F-Fluoromisonidazole Hypoxia PET/CT Diagnostic Interpretation Criteria and Validation of Interreader Reliability, Reproducibility, and Performance

Rick Wray, Audrey Mauguen, Laure Michaud, Doris Leithner, Randy Yeh, Nadeem Riaz, Rosna Mirtcheva, Eric Sherman, Richard Wong, John Humm, Nancy Lee, Heiko Schöder

Journal of Nuclear Medicine · 2024

DOI: 10.2967/jnumed.124.267775 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Journal of Nuclear Medicine, 2024. Verfasst von Rick Wray und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York. Hauptthemen laut MEDLINE: Misonidazole, Positron Emission Tomography Computed Tomography. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MisonidazolePositron Emission Tomography Computed TomographyAgedFemaleHumansMaleMiddle AgedImage Interpretation, Computer-AssistedObserver VariationOropharyngeal NeoplasmsReproducibility of ResultsTumor Hypoxia

Stichwörter der Autor:innen

FMISOPET/CTfluoromisonidazoleinterpretation criteria

Substanzen

fluoromisonidazoleMisonidazole

Autor:innen und Institutionen

  • Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York; and.
  • Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York.

Förderung

  • NCI NIH HHS

Zitieren

APA

Wray, R., Mauguen, A., Michaud, L., Leithner, D., Yeh, R., Riaz, N., Mirtcheva, R., Sherman, E., Wong, R., Humm, J., Lee, N., & Schöder, H. (2024). Development of 18 F-Fluoromisonidazole Hypoxia PET/CT Diagnostic Interpretation Criteria and Validation of Interreader Reliability, Reproducibility, and Performance. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.124.267775

Vancouver

Wray R, Mauguen A, Michaud L, Leithner D, Yeh R, Riaz N, et al. Development of 18 F-Fluoromisonidazole Hypoxia PET/CT Diagnostic Interpretation Criteria and Validation of Interreader Reliability, Reproducibility, and Performance. Journal of Nuclear Medicine. 2024. doi:10.2967/jnumed.124.267775

BibTeX
@article{Wray2024,
  author = {Wray, Rick and Mauguen, Audrey and Michaud, Laure and Leithner, Doris and Yeh, Randy and Riaz, Nadeem and Mirtcheva, Rosna and Sherman, Eric and Wong, Richard and Humm, John and Lee, Nancy and Schöder, Heiko},
  title = {Development of 18 F-Fluoromisonidazole Hypoxia PET/CT Diagnostic Interpretation Criteria and Validation of Interreader Reliability, Reproducibility, and Performance},
  journal = {Journal of Nuclear Medicine},
  year = {2024},
  doi = {10.2967/jnumed.124.267775}
}
Kostenlos starten →